Decnupaz Injection, Powder, Lyophilized, For Solution
Product Images NDC 0074-0282

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Decnupaz (NDC 0074-0282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pivekimab Sunirine-pvzy Has The Following Structure: (Pivekimab Sunirine Pvek 01)

FDA Label Image

Principal Display Panelndc 0074-0282-02decnupaztm Pivekimab Sunirine-pvzyfor Injection2 mg Per Vialwarning: Hazardous Drugfor Intravenous Infusion Afterreconstitution And Two Dilutions1 Single-dose Vialdiscard Unused Portiondispense The Enclosed Medicationguide To Each Patientrx Onlyabbvie (Pivekimab Sunirine Pvek 02)

Principal Display Panelndc 0074-0282-02decnupaztm Pivekimab Sunirine-pvzyfor Injection2 mg Per Vialwarning: Hazardous Drugfor Intravenous Infusion Afterreconstitution And Two Dilutions1 Single-dose Vialdiscard Unused Portiondispense The Enclosed Medicationguide To Each Patientrx Onlyabbvie (Pivekimab Sunirine Pvek 02)
"Decnupaz 2 mg per vial injection for PLT R"*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.